HEALTH CATALYST, INC. (HCAT) Social Stream
HEALTH CATALYST INC (HCAT) Price Targets From Analysts
Use the tables below to see what analysts covering HEALTH CATALYST INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 10 | $70 | $43 | $61 | $9.26 | 558.75% |
| 2021-11-15 | 10 | $70 | $44 | $61.777 | $9.26 | 567.14% |
| 2021-12-02 | 10 | $70 | $44 | $60.111 | $9.26 | 549.15% |
| 2021-12-08 | 9 | $70 | $48 | $61.5 | $9.26 | 564.15% |
| 2021-12-20 | 9 | $70 | $48 | $59.875 | $9.26 | 546.6% |
| 2022-03-01 | 9 | $70 | $35 | $56 | $9.26 | 504.75% |
| 2022-03-03 | 9 | $66 | $31 | $50.125 | $9.26 | 441.31% |
| 2022-03-07 | 9 | $66 | $31 | $46.625 | $9.26 | 403.51% |
| 2022-03-09 | 9 | $60 | $31 | $45.875 | $9.26 | 395.41% |
| 2022-04-01 | 9 | $60 | $28 | $45.5 | $9.26 | 391.36% |
| 2022-04-14 | 10 | $60 | $28 | $44.777 | $9.26 | 383.55% |
| 2022-05-11 | 10 | $60 | $18 | $37.444 | $9.26 | 304.36% |
| 2022-05-23 | 11 | $60 | $17 | $29.25 | $9.26 | 215.87% |
| 2022-06-28 | 11 | $60 | $17 | $28.333 | $9.26 | 205.97% |
| 2022-08-02 | 11 | $39 | $17 | $25.416 | $9.26 | 174.47% |
| 2022-08-05 | 11 | $39 | $16 | $24.166 | $9.26 | 160.97% |
| 2022-08-09 | 10 | $39 | $15 | $22.5 | $9.26 | 142.98% |
| 2022-08-10 | 9 | $39 | $15 | $20.916 | $9.26 | 125.87% |
| 2022-09-13 | 11 | $39 | $11 | $20.083 | $9.26 | 116.88% |
| 2022-09-25 | 11 | $39 | $11 | $19.833 | $9.26 | 114.18% |
| 2022-09-26 | 11 | $39 | $11 | $19.5 | $9.26 | 110.58% |
| 2022-10-25 | 12 | $39 | $9 | $18.666 | $9.26 | 101.58% |
| 2022-10-31 | 13 | $39 | $9 | $18 | $9.26 | 94.38% |
| 2022-11-10 | 13 | $39 | $8 | $17 | $9.26 | 83.59% |
| 2022-11-15 | 13 | $39 | $8 | $16.923 | $9.26 | 82.75% |
The Trend in the Analyst Price Target
Over the past 30 months, HCAT's average price target has gone down $23.
HCAT reports an average of 98.19% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-12-20 | 8 | 70 | 48 | 59.875 | 36.68 | 63.24% |
| 2022-03-03 | 9 | 66 | 31 | 50.125 | 26.68 | 87.87% |
| 2022-04-01 | 10 | 60 | 28 | 45.500 | 27.63 | 64.68% |
| 2022-05-11 | 10 | 60 | 18 | 37.444 | 12.61 | 196.94% |
| 2022-08-05 | 11 | 39 | 16 | 24.000 | 11.35 | 111.45% |
HCAT Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.92 | 7 | 0 | 6 | 0 | 0 | 13 |
The Trend in the Broker Recommendations
HCAT's average broker recommendation rating worsened by 0.92 over the prior 32 months.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- HCAT has a greater upside potential (average analyst target price relative to current price) than 2992.25% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, HEALTH CATALYST INC's variance in analysts' estimates is lower than -2691.17% of them.
- HEALTH CATALYST INC's number of analysts covering the stock is greater than 2860.63% of stocks in the mid market cap category.
- HEALTH CATALYST INC's average analyst price target is greater than 1674.93% of stocks in the mid market cap category.
In the Business Services industry, YALA, PUBM, and DSP are the three stocks most similar to HEALTH CATALYST INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
What is the outlook for HCAT? Use POWR Ratings for clearer insight into price direction.